 BEIJING, Oct. 15, 2021 PRNewswire -- Concord Medical Services Holdings Limited Concord Medical or the Company NYSE: CCM, a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers, premium cancer hospitals, and specialty cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2020 the Annual Report with the U.S. Securities and Exchange Commission. An electronic copy of the Annual Report can be accessed on Concord Medicals investor relations website at and on the SECs website at 